Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novartis
AddedMar 19, 2024
UpdatedJul 11, 2026
Novartis

Novartis

Public

Innovative Swiss-American pharma creating transformative treatments.

HQ
Basel, Basel-Stadt, CH
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Founded in March 1996 through the merger of Ciba-Geigy and Sandoz, Novartis Institutes for BioMedical Research (NIBR) is a pioneering pharmaceutical research organization headquartered in Basel, Switzerland. NIBR's core mission is to transform patient care by focusing on unmet medical needs and advancing disease understanding. They specialize in developing innovative pharmaceutical drugs, generic drugs, and over-the-counter treatments. NIBR's unique approach integrates early-stage research with clinical practice to identify and advance the most promising drug candidates through Proof-of-Concept clinical trials.

Notable figures associated with Novartis include CEO Vasant Narasimhan and Chairman Jörg Reinhardt. The organization has achieved significant milestones in drug development and has a substantial impact on global healthcare. Novartis' commitment to innovation and patient-centric research has led to breakthroughs in various therapeutic areas, enhancing the quality of life for millions worldwide. Their work continues to set industry standards and drive advancements in pharmaceutical research and development.

Novartis - Similar Companies

Novartis Institutes For Biomedical Research logo

Novartis Institutes For Biomedical Research

novartis.com

Novartis Pharma logo

Novartis Pharma

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Lonza logo

Lonza

Viatris logo

Viatris

viatris.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Pfizer logo

Pfizer

pfizer.com

Roche Holding logo

Roche Holding

roche.com

UCB logo

UCB

ucb.com

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Bayer logo

Bayer

bayer.com

Boehringer Ingelheim logo

Boehringer Ingelheim

AbbVie logo

AbbVie

abbvie.com

Genentech logo

Genentech

gene.com

Novartis - Quick Facts

Who are Novartis' competitors?

Companies similar to Novartis include Novartis Institutes For Biomedical Research, Novartis Pharma, Bristol Myers Squibb and Lonza.

When was Novartis founded?

Novartis was founded in 2002.

Where is Novartis' headquarters located?

Novartis' headquarters is located in Basel, Basel-Stadt, CH.

When was Novartis' last funding round?

Novartis' most recent funding round was for $6.5M (USD) in February 2018.

How much has Novartis raised to-date?

As of Feb 14, 2018, Novartis has raised a total of $6.5M (USD).

How many employees does Novartis have?

Novartis has 101,703 employees as of Feb 6, 2024.

Novartis - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Unique IDs
  • secCik: 0001114448
  • ticker: NVS
  • ticker: NVSEF
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339115Ophthalmic Goods Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3827Optical Instruments And Lenses
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified